Scientists have discovered that the survival of cancer stem cells is dependent on the ‘Hedgehog signaling pathway’. Targeting this pathway had previously shown no effect on the growth of colorectal cancer. Now, scientists have demonstrated that using different drugs to target a specific aspect of the pathway may yield better treatment outcomes for patients.